Trientine Tetrahydrochloride
Trientine tetrahydrochloride is the tetrahydrochloride salt form of trientine (triethylenetetramine), providing a more stable and water-soluble formulation of the copper-chelating agent used in Wilson's disease. See trientine for complete pharmacological details. This salt form has been developed as an alternative formulation to address stability issues with previous trientine preparations.
Molekularmasse
292,1000 g/mol
TPSA
76,10 Ų
Wirkmechanismus
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
2D-Struktur
Cite this structure
Embed this structure
SMILES
Cl.Cl.Cl.Cl.NCCNCCNCCN
InChI
InChI=1S/C6H18N4.4ClH/c7-1-3-9-5-6-10-4-2-8;;;;/h9-10H,1-8H2;4*1H
Molecular Formula
C6H22Cl4N4
HBD / HBA
8 / 4
Rotierbare Bindungen
7
Schwere Atome
14
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
Trientine tetrahydrochloride is the tetrahydrochloride salt form of trientine (triethylenetetramine), providing a more stable and water-soluble formulation of the copper-chelating agent used in Wilson's disease. See trientine for complete pharmacological details. This salt form has been developed as an alternative formulation to address stability issues with previous trientine preparations.
Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.
Yes, Trientine Tetrahydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5095420. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 71434. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="trientine-tetrahydrochloride"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/trientine-tetrahydrochloride/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/trientine-tetrahydrochloride/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/trientine-tetrahydrochloride/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="trientine-tetrahydrochloride"></drugfyi-drug>